Merck in Late-Stage Talks to Acquire Prometheus Biosciences

The move could give the big drugmaker promising immune disease treatments

image
Merck has been looking for deals to add new products to its pipeline. Photo: BRENDAN MCDERMID/REUTERS

Merck & Co. is in late-stage talks to acquire Prometheus Biosciences Inc., according to people familiar with the matter, a move that could give the big drugmaker promising immune disease treatments.

A deal for Prometheus could be announced as soon as Sunday, the people said, cautioning the talks could still fall apart.

What's News

Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Continue reading your article with
a WSJ subscription

Subscribe Now

Already a subscriber? Sign In

Sponsored Offers
  • Walmart:
    20% off your order with Walmart promo code
  • Saks Fifth Avenue:
    Saks Fifth Avenue promo code: 20% off first order
  • Kohl's:
    Save 15% on orders of $100+ with Kohl's coupon
  • adidas:
    adidas Promo Code - Up to 50% Off 3-Stripe Favorites
  • Nike:
    Nike promo code: Members save up to 20% on select styles
  • American Eagle Outfitters:
    15% off American Eagle promo code